Globe Life stock falls as Q2 2026 EPS tops estimates
Globe Life's stock declined after its Q2 2026 earnings update, despite adjusted EPS of $3.61 being close to the $3.68 estimate and a full-year net operating EPS outlook of $15.55 to $15.95. The company's P/E ratio of 11.4x is below its 5-year median, and its core business remains individual life insurance and supplemental health coverage. The stock closed at $171.74, a 3.56% drop, and has a market capitalization of $14.054 billion.
Skyward Specialty Insurance Group, Inc. (NASDAQ:SKWD) Receives Average Rating of "Moderate Buy" from Brokerages
Skyward Specialty Insurance Group (NASDAQ: SKWD) has received an average rating of "Moderate Buy" from thirteen brokerages, with an average 12-month price target of $68.64, significantly higher than its current share price of $56.40. The company reported strong Q4 earnings of $1.30 per share, surpassing analyst expectations, and demonstrated robust financial health with a 18.72% return on equity. Institutional investors hold a substantial 94.83% of the shares, indicating strong confidence in the company, despite a recent insider share sale.
Globe Life Inc (GL) Shares Fall 3.7% -- What GF Score of 85 Tells Investors
Globe Life Inc (GL) shares dropped 3.7% to $171.46, marking it as 14.5% overvalued according to GuruFocus's GF Value™ of $149.77. Despite a strong GF Score™ of 85/100, indicating solid performance in growth and profitability, the company faces concerns regarding its financial strength and significant insider selling without any buying activity, suggesting a cautious outlook from those closest to the company.
Globe Life stock holds below consensus as buybacks and institutional demand support the valuation.
Globe Life Inc. stock is currently trading below the analyst consensus target, supported by recent institutional buying and a significant share repurchase program. The insurer's valuation shows a potential upside, with shares trading at a discount compared to the $191.67 consensus target, further bolstered by a $2.50 billion buyback authorization and a history of regular dividends. This indicates strong institutional confidence and a structured capital-return policy shaping the company's risk-reward profile.
Globe Life stock trades just below consensus as guidance lift supports valuation
Globe Life Inc. (GL) stock is trading in the high-$180s, just below the analyst consensus target of $191.67, which implies a 5.9% upside. This valuation is supported by the company's raised 2026 earnings guidance, strong health premium growth, and consistent share repurchases and dividends. While recent share performance has lagged the broader industry, analysts view the stock as offering a solid growth projection at a discount relative to some peers.
Globe Life stock holds steady as investors digest recent gains
Globe Life Inc. stock is trading steadily around $180.94 as investors consolidate recent gains and assess the insurer's earnings trajectory and valuation. The stock's current price is slightly below the consensus target price of $191.67, implying a moderate upside potential of approximately 5.9%. Institutional interest remains notable, with new buyers entering positions at current price levels, suggesting confidence in Globe Life's risk-reward profile.
ETFs Investing in Globe Life Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Globe Life Inc., providing details such as market value, weight, issuer, management style, expense ratio, and 3-year NAV total return for each fund. The funds aim to make investing in stocks more accessible and offer diversified opportunities at lower risk.
Globe Life's $2.5 Billion Buyback Expansion Tests Whether Buybacks Are Masking Weak Underwriting
Globe Life Inc. has increased its share repurchase authorization to $2.5 billion and declared a $0.33 quarterly dividend, following a quarter with weaker underwriting margins and softer sales. While the stock has performed well, trading near its estimated fair value, questions arise about whether these capital allocation moves are compensating for operational weaknesses rather than reflecting underlying business strength. The company's planned Bermuda reinsurance affiliate could boost future free cash flow, but near-term focus remains on policy growth and margin stabilization.
Summit Asset Management LLC Buys Shares of 5,659 Globe Life Inc. $GL
Summit Asset Management LLC has acquired 5,659 shares of Globe Life Inc. (NYSE:GL) in the second quarter, a stake valued at approximately $1.01 million. This comes as institutional investors and hedge funds own 81.61% of the company. Globe Life recently reported quarterly revenue of $1.60 billion, an 8% increase year-over-year, despite missing EPS consensus estimates, and authorized a $2.5 billion stock repurchase program.
Globe Life (GL) Could Be 5% Undervalued After Weak Q2 Sales And Underwriting Setbacks
Globe Life (GL) is currently valued at $181.0, with Simply Wall St's narrative suggesting it is 4.8% undervalued with a fair value of $190.09 per share. The company faces challenges from weak Q2 2026 sales and underwriting setbacks but has increased its share repurchase authorization and affirmed its quarterly dividend. The planned Bermuda reinsurance affiliate is expected to boost free cash flow and financial flexibility by 2027, potentially increasing EPS, though risks from ongoing DOJ and SEC investigations remain.
7,319 Shares in Globe Life Inc. $GL Acquired by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. recently acquired a new position of 7,319 shares in Globe Life Inc. (NYSE:GL) valued at approximately $1.308 million during the second quarter. This article details significant institutional investments, insider trading activities including sales by EVP Michael Clay Majors and CEO James Matthew Darden, and recent analyst ratings for Globe Life. It also provides an overview of the company's financial performance, stock price action, and dividend announcement.
Lincoln National Stock And 2 Life Insurers Built For Higher Long Term Yields
This article examines three U.S. life insurers and long-duration liability managers—Lincoln National (LNC), Brookfield Wealth Solutions (BNT), and Globe Life (GL)—that are well-positioned to benefit from higher long-term interest rates. It details how their business models, which involve reinvesting long-dated cash flows, could lead to spread expansion and stronger cash generation in the current interest rate environment. The analysis highlights their respective market positions, financial performance, and key risks, suggesting these companies warrant closer review for investors expecting sustained higher yields.
Elastic Target of Unusually High Options Trading (NYSE:ESTC)
Elastic N.V. (NYSE:ESTC) experienced unusually high options trading, with investors purchasing 4,771 call options, a 101% increase above the average. This activity follows solid quarterly results where Elastic reported adjusted EPS of $0.61 and a 16% year-over-year revenue increase to $450.68 million. Analyst sentiment for ESTC is moderately bullish, with a consensus "Moderate Buy" rating and an average price target of $80.33.
What Are Wall Street Analysts' Target Price for Globe Life Stock?
Globe Life Inc. (GL) has outperformed the broader market, with its stock up 30.6% over the past 52 weeks and 29.4% YTD. Despite beating Q2 2026 earnings estimates, the stock dropped due to weak sales trends and underwriting performance. Analysts maintain a "Moderate Buy" consensus rating with a mean price target of $192.64, suggesting a 6.4% upside.
Globe Life Inc. stock outperforms competitors on strong trading day
Globe Life Inc. (GL) shares rose 1.55% to $180.67 on Thursday, breaking a four-day losing streak. The stock's performance outpaced the broader market, with the S&P 500 Index and Dow Jones Industrial Average also seeing gains. This positive trading day occurred amidst an overall strong session for the stock market.
Globe Life (GL) holder Frank Svoboda files to sell 16,500 common shares
Frank Svoboda, a shareholder in Globe Life Inc. (GL), has filed a notice to sell 16,500 shares of common stock through a stock option exercise. The transaction will be handled by Apex Clearing and traded on the NYSE. This planned sale follows previous sales by Svoboda totaling 40,000 shares over the prior three months in May and June 2026.
Does Globe Life’s New US$2.5 Billion Buyback Shift the Capital Allocation Story for GL?
Globe Life Inc. has authorized a new US$2.5 billion stock buyback program, effective August 15, 2026, while maintaining its quarterly dividend of US$0.33 per share. This significant buyback emphasizes the Board's focus on returning excess capital to shareholders. The article discusses how this impacts Globe Life's investment narrative, capital allocation, and current analyst expectations, especially in light of ongoing regulatory investigations.
Zacks Industry Outlook Highlights Aflac, Globe Life, Trupanion and Employers Holdings
The Zacks Accident and Health Insurance industry is poised for growth due to increased underwriting exposure and demand for group insurance, benefiting companies like Aflac, Globe Life, Trupanion, and Employers Holdings. However, rising inflation and medical costs pose challenges. The industry is adopting technology and seeing improved claims frequency, though pricing pressure and medical inflation remain concerns.
Zacks Industry Outlook Highlights Aflac, Globe Life, Trupanion and Employers Holdings
The Zacks Accident and Health Insurance industry is poised for growth due to increased underwriting exposure and demand for group insurance, benefiting companies like Aflac, Globe Life, Trupanion, and Employers Holdings. However, challenges such as rising medical costs and persistent inflation could temper this growth. The industry is also seeing accelerated adoption of technology, including AI, to improve efficiency and reduce claims expenses, despite potential increases in expense ratios.
Zacks Industry Outlook Highlights Aflac, Globe Life, Trupanion and Employers Holdings
The Zacks Accident and Health Insurance industry is expected to benefit from increased underwriting exposure, with Aflac, Globe Life, Trupanion, and Employers Holdings poised for growth due to rising demand for group insurance. However, the industry faces challenges from persistent medical inflation and pricing pressures, despite advancements in technology like AI and improved claims frequency. The industry currently holds a Zacks Industry Rank #214, indicating bleak near-term prospects despite individual company advancements.
Reinsurance Group of America, Incorporated (NYSE:RGA) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Reinsurance Group of America (NYSE:RGA) has received a "Moderate Buy" consensus recommendation from eleven brokerages, with an average 12-month price target of $257.11. The company recently reported strong quarterly earnings of $8.89 per share, significantly beating estimates, and revenue increased by 18.5% year over year. RGA also increased its quarterly dividend from $0.93 to $0.98 per share, resulting in a 1.6% annualized yield.
Globe Life EVP Robert Mitchell sells over $4.2m in shares
Globe Life's EVP, General Counsel, and Chief Risk Officer, Robert Brian Mitchell, sold over $4.2 million worth of shares on August 7, 2026, after exercising employee stock options. The sales occurred across multiple transactions at prices ranging from $182.38 to $185.50 per share. This insider sale follows a 28% surge in Globe Life shares over the past six months, with InvestingPro indicating the stock is trading above its Fair Value and is considered overvalued.
Globe Life Inc. stock underperforms Wednesday when compared to competitors
Globe Life Inc. (GL) stock dropped 1.73% on Wednesday, closing at $177.91, marking its fourth consecutive day of losses. This underperformance occurred on a mixed trading day, with the S&P 500 Index rising and the Dow Jones Industrial Average falling slightly.
4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs
The Zacks Accident and Health Insurance industry is poised for growth due to increased underwriting exposure and demand for group insurance, despite challenges from inflation and rising medical costs. The industry is adopting technology like AI and telemedicine to enhance operations and manage costs. Four key insurers, Aflac, Globe Life, Trupanion, and Employers Holdings, are highlighted for their strategic advancements and potential for future growth.
Globe Life Inc. stock underperforms Tuesday when compared to competitors
Shares of Globe Life Inc. (GL) fell by 1.21% on Tuesday, closing at $181.04. This decline occurred during a generally down day for the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average also posting losses. This marked the third consecutive day of losses for Globe Life Inc. stock.
Globe Life(GL.US) Officer Sells US$4.22 Million in Common Stock
A Globe Life (GL.US) officer recently sold common stock valued at US$4.22 million. This transaction indicates a significant insider sale within the company.
Globe Life EVP Robert Mitchell sells over $4.2m in shares
Robert Brian Mitchell, EVP at Globe Life Inc., sold over $4.2 million worth of shares on August 7, 2026, after exercising employee stock options. This sale follows a significant 28% surge in Globe Life's stock price over the last six months. Mitchell still holds substantial direct and indirect ownership in the company.
Does Globe Life’s New US$2.5 Billion Buyback Shift the Capital Allocation Story for GL?
Globe Life Inc. has announced a new US$2.5 billion share buyback authorization, effective August 15, 2026, alongside reaffirming its quarterly dividend of US$0.33 per share. This move underscores the Board's commitment to returning capital to shareholders, although the company still faces unresolved regulatory investigations. The buyback could influence future earnings forecasts and the company's valuation, which analysts currently estimate with a potential upside.
Does Globe Life’s New US$2.5 Billion Buyback Shift the Capital Allocation Story for GL?
Globe Life Inc. has authorized a new US$2.5 billion share buyback, effective August 15, 2026, and maintained its quarterly dividend at US$0.33 per share. This move emphasizes the company's commitment to returning capital to shareholders, though analysts note that ongoing regulatory investigations remain a key concern for investors. The buyback reinforces the capital return strategy but doesn't change the need for digital execution or address potential risks from regulatory overhangs.
Share Repurchase Program Approved by Globe Life (NYSE:GL) Board of Directors
Globe Life's Board of Directors has approved a new $2.5 billion share repurchase program, allowing the company to buy back up to 17.7% of its outstanding shares. The insurer reported an 8% year-over-year increase in quarterly revenue to $1.60 billion but missed earnings estimates, posting $3.61 per share against an expected $3.67. Despite significant insider selling totaling $33.5 million, analysts maintain a "Moderate Buy" rating with an average price target of $191.67, and the company also declared a quarterly dividend of $0.33 per share.
Globe Life EVP, General Counsel and CRO Robert Brian Mitchell disposes of shares worth $4.22 million
Robert Brian Mitchell, EVP, General Counsel, and CRO of Globe Life, sold 23,000 shares of the company's stock, valued at approximately $4.22 million, after exercising employee stock options. The transactions reduced his direct holdings from 30,980 to 7,980 common shares. This news brief was generated by AI and references an original SEC filing by Globe Life Inc.
Globe Life announces Q3 2026 distribution of R$ 0.06 per unit
Globe Life has announced a distribution of R$ 0.06 per unit for the third quarter of 2026. Shares will trade with entitlement through October 1, 2026, with payment scheduled for November 6, 2026. This news brief was generated by Public Technologies using AI and is for informational purposes only.
Weekly Recap: Globe Life Inc. Q2 2026 results and $0.33 cash dividend
Globe Life Inc. (NYSE:GL) reported Q2 2026 revenue of $1.6 billion and net income of $288 million, with an EPS of $3.65. The company saw a 6% rise in total premium and a 10% increase in net sales, attributed to gains in Medicare Supplement and digital DTC, and a 41% life underwriting margin. Additionally, Globe Life declared a quarterly cash dividend of $0.33 per share.
Principal Financial Group Inc (PFG) Earnings Forecast: Future EPS & Revenue Growth Estimates
The article provides an earnings forecast for Principal Financial Group Inc (PFG), indicating an earnings forecast score of 6.00, ranking 86th in the Insurance industry. Analysts have set an average price target of $88.50, with a "Hold" rating based on 16 analysts. The company's expected revenue for the next quarter is $4.20 billion, and its EPS for the previous quarter was $1.95, with a projected EPS of $2.51 for the next quarter.
Nearly $11.5B Returned: Globe Life Authorizes New Buyback
Globe Life (NYSE: GL) has announced a new authorization to repurchase up to $2.5 billion of common stock, effective August 15, 2026, replacing all prior authorizations. Since its inception in 1986, the company's repurchase program has returned nearly $11.5 billion to shareholders. This move reflects the Board's confidence in Globe Life's long-term value creation and its consistent capital allocation strategy, prioritizing insurance operations growth before returning excess capital to shareholders.
Globe Life Announces New Share Repurchase Authorization
Globe Life Inc. announced a new authorization to repurchase up to $2.5 billion of its common stock, effective August 15, 2026, replacing prior authorizations. This decision reflects the Board's confidence in the company's ability to generate reliable free cash flow and its commitment to maximizing long-term shareholder value through a disciplined capital allocation strategy. Since 1986, Globe Life has returned nearly $11.5 billion to shareholders through buybacks.
Jackson Financial Inc. (JXN) stock price, news, quote and history
This article provides a comprehensive overview of Jackson Financial Inc. (JXN), including its current stock price, recent performance metrics, financial data, and analyst insights. It details the company's business segments, product offerings, and market position within the life insurance and financial services industry. The page also features comparative data with similar companies and key financial highlights.
Bank of America Corp DE Lowers Stock Position in Globe Life Inc. $GL
Bank of America Corp DE reduced its stake in Globe Life Inc. by 7.2% in the first quarter, selling 49,570 shares but still owning 641,343 shares worth $89.3 million. Despite this, analysts maintain a "Moderate Buy" rating for Globe Life, with several recent price target increases. The company reported an 8% increase in quarterly revenue to $1.60 billion, though EPS of $3.61 missed estimates, and insiders sold over $35.9 million worth of stock in the last three months.
MetLife Inc (MET) Earnings Forecast: Future EPS & Revenue Growth Estimates
MetLife Inc (MET) has an earnings forecast score of 7.80, ranking 26th in the Insurance industry. The average price target is $92.50, with a consensus of 20 analysts suggesting a "Buy" trend. Analysts expect the next quarter's EPS to be $2.29 and revenue to be $20.16 billion.
DaVita Inc. (DVA) Stock Forecasts
Morningstar analyst Julie Utterback reports on DaVita Inc. (DVA), a major dialysis service provider, stating that the company's shares fell after management maintained its 2026 outlook. The report highlights DaVita's significant market share in the U.S. dialysis sector and its large patient base, primarily served by government payers. The article also provides related analyst reports from other firms with their target price adjustments.
Globe Life Inc. Announces Director Retirement in August 7, 2026 Form 8-K Filing
Globe Life Inc. announced the retirement of a director in an August 7, 2026 Form 8-K filing. This news was posted on August 8, 2026, and is part of the latest corporate news updates from the company. The article also mentions related corporate filings and financial news from other companies.
Globe Life Inc. (GL) Announces Board Member David A. Rodriguez R
Globe Life Inc. (GL) announced that its board member, David A. Rodriguez, retired from the Board of Directors effective August 4, 2026, for personal reasons, with no disagreements cited between him and the company. The company has not yet indicated plans to fill the vacancy. GuruFocus notes Globe Life's fair value, GF Score, and guru holdings.
DaVita Inc. (DVA) Stock Forecasts
DaVita Inc. (DVA) saw its stock fall after management maintained its 2026 outlook. Morningstar's senior analyst, Julie Utterback, covers the company, which is a leading provider of dialysis services in the U.S. with a significant market share. The report highlights DaVita's market position and analyst ratings, including a current price of $183.77.
Globe Life Inc. Declares Quarterly Dividend of $0.33 (NYSE:GL)
Globe Life Inc. (NYSE:GL) has declared a quarterly dividend of $0.33 per share, payable on October 30, 2026, to shareholders of record on October 5, 2026. This dividend, representing an annualized payout of $1.32 and a 0.7% yield, marks the 20th consecutive year the company has increased its dividend. Despite missing recent EPS estimates, the dividend is well-covered by earnings, with a low payout ratio of 8.8%.
Globe Life Inc.: David Rodriguez Retired From the Board >GL
Globe Life Inc. announced that David Rodriguez retired from its board of directors on August 6, 2026. His retirement was not due to any disagreement with the company's operations, policies, or practices.
Globe Life (NYSE: GL) director David A. Rodriguez retires from board
Globe Life Inc. announced that director David A. Rodriguez retired from its Board of Directors effective August 4, 2026, due to personal reasons. The company clarified that his departure was not related to any disagreements regarding its operations, policies, or practices. Globe Life's common stock (GL) and junior subordinated debentures (GL PRD) are both traded on the New York Stock Exchange.
Globe Life Inc. stock underperforms Friday when compared to competitors
Globe Life Inc. (GL) stock declined 1.17% on Friday, closing at $183.85, despite a positive trading session for the broader market. The S&P 500 Index and Dow Jones Industrial Average both saw gains. The stock is 4.02% below its 52-week high of $191.55, achieved on July 17th.
Press Release: GLOBE LIFE INC. DECLARES DIVIDEND
Globe Life Inc. announced that its Board of Directors has declared a quarterly dividend of $0.22 per share on its common stock. The dividend is payable on November 1, 2024, to shareholders of record as of the close of business on October 11, 2024.
GLOBE LIFE INC. DECLARES DIVIDEND
Globe Life Inc. (NYSE: GL) has announced that its Board of Directors declared a quarterly dividend of $0.33 per share. This dividend will be paid on October 30, 2026, to shareholders of record as of October 5, 2026. Globe Life Inc. specializes in life and supplemental health insurance for the middle-income market.
Globe Life Keeps Quarterly Dividend at $0.33 a Share, Payable Oct. 30 to Holders of Record Oct. 5
Globe Life Inc. (NYSE: GL) has announced that it will maintain its quarterly dividend at $0.33 per share. The dividend is scheduled to be paid on October 30 to shareholders of record as of October 5. This news comes amidst recent analyst target adjustments for Globe Life.
